These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 16194477

  • 1. [Use of rifabutin in cases of toxicity to rifampicin].
    Moreno González B, Rodríguez Blanco A, Rodríguez Barrientos R, Vidal Pérez JL, Noguerado Asensio A.
    Rev Clin Esp; 2005 Sep; 205(9):430-2. PubMed ID: 16194477
    [Abstract] [Full Text] [Related]

  • 2. A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.
    Tattevin P, Revest M, Dupont M, Arvieux C, Michelet C.
    Clin Infect Dis; 2003 Jan 01; 36(1):127-8. PubMed ID: 12491218
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Experience with rifabutin replacing rifampin in the treatment of tuberculosis.
    Horne DJ, Spitters C, Narita M.
    Int J Tuberc Lung Dis; 2011 Nov 01; 15(11):1485-9, i. PubMed ID: 22008761
    [Abstract] [Full Text] [Related]

  • 5. Rifabutin: where do we stand in 2016?
    Crabol Y, Catherinot E, Veziris N, Jullien V, Lortholary O.
    J Antimicrob Chemother; 2016 Jul 01; 71(7):1759-71. PubMed ID: 27009031
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Global access of rifabutin for the treatment of tuberculosis - why should we prioritize this?
    Rockwood N, Cerrone M, Barber M, Hill AM, Pozniak AL.
    J Int AIDS Soc; 2019 Jul 01; 22(7):e25333. PubMed ID: 31318176
    [Abstract] [Full Text] [Related]

  • 8. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W, Sassella D, Wynne BA.
    Scand J Infect Dis Suppl; 1995 Jul 01; 98():22-6. PubMed ID: 8867175
    [Abstract] [Full Text] [Related]

  • 9. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
    Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP.
    Liver Transpl; 2013 Apr 01; 19(4):457-61. PubMed ID: 23526600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical experience using rifabutin for treating infection with Mycobacterium tuberculosis in elderly Japanese patients].
    Morimoto K, Yoshiyama T, Kuse M, Okumura M, Sasaki Y, Yoshimori K, Ogata H, Kurashima A, Kudoh S.
    Kekkaku; 2013 Aug 01; 88(8):625-8. PubMed ID: 24044166
    [Abstract] [Full Text] [Related]

  • 12. Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
    Schmaltz CAS, Demitto FO, Sant'Anna FM, Rolla VC.
    Mem Inst Oswaldo Cruz; 2019 Feb 11; 114():e180420. PubMed ID: 30758392
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rifabutin as salvage therapy for cases of chronic multidrug-resistant pulmonary tuberculosis in Taiwan.
    Lee CN, Lin TP, Chang MF, Jimenez MV, Dolfi L, Olliaro P.
    J Chemother; 1996 Apr 11; 8(2):137-43. PubMed ID: 8708745
    [Abstract] [Full Text] [Related]

  • 15. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J, Munsiff SS, Driver CR, Sackoff J.
    Clin Infect Dis; 2005 Jul 01; 41(1):83-91. PubMed ID: 15937767
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Update on rifampin, rifabutin, and rifapentine drug interactions.
    Baciewicz AM, Chrisman CR, Finch CK, Self TH.
    Curr Med Res Opin; 2013 Jan 01; 29(1):1-12. PubMed ID: 23136913
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rifabutin.
    Tuberculosis (Edinb); 2008 Mar 01; 88(2):145-7. PubMed ID: 18486056
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of tuberculosis with rifabutin in a renal transplant recipient.
    López-Montes A, Gallego E, López E, Pérez J, Lorenzo I, Llamas F, Serrano A, Andrés E, Illescas L, Gómez C.
    Am J Kidney Dis; 2004 Oct 01; 44(4):e59-63. PubMed ID: 15384035
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.